How Is Restricted Stock Valued? Complete Guide with Examples

📌 Quick Navigation

Valuation Methods for Restricted Stock
The Role of Discounts for Lack of Marketability (DLOM)
IRS 409A and Fair Market Value
Restricted Stock vs. Stock Options
How to Negotiate Your Restricted Stock Value
Common Valuation Mistakes
Frequently Asked Questions

I’ve spent years helping startups set up equity plans and advising employees on what their restricted stock is really worth. One thing I keep seeing: people confuse “number of shares” with “dollar value.” But valuing restricted stock isn’t as simple as multiplying shares by the latest 409A price. There’s a whole layer of illiquidity discounts, vesting schedules, and tax implications that can cut the perceived value in half. Let me walk you through how it works—no fluff, just the stuff that matters.

Valuation Methods for Restricted Stock

At its core, restricted stock (like RSUs or restricted shares) is valued the same way as unrestricted stock, but with an extra haircut for restrictions. The starting point is the fair market value (FMV) of the common stock on the grant date. For private companies, that FMV comes from a 409A valuation performed by an independent appraiser. For public companies, it’s the closing price on the grant date. But that’s only the beginning.

1. Market Approach

If the company has a recent funding round or secondary transaction, the price per share in those deals is a strong indicator. But here’s the catch: investors often get preferred stock with extra rights, so the common stock (which restricted stock usually is) can be worth 10-30% less. I’ve seen startups use the “rights-based” method to adjust for this. For example, if Series B priced preferred at $10/share, common might be valued at $7-8 after applying a “common stock discount.”

2. Income Approach (Discounted Cash Flow)

For pre-revenue startups, appraisers often project future cash flows and discount them back. This gets messy fast—small changes in growth assumptions swing the valuation wildly. In my experience, this method is more art than science, and it’s why most private companies lean on market comparables. Still, the IRS expects you to at least consider it for 409A reports.

3. Asset-Based Approach

Rarely used for tech startups unless they’re asset-heavy (biotech with patents, for instance). You sum up net asset value and allocate to shares. Not very relevant for most restricted stock scenarios.

  💡 Real-world example: A Series-A startup (let’s call it CloudSync) had a 409A valuation of $2.50/share. They granted me 10,000 restricted shares. At face value, that’s $25,000. But because the stock can’t be sold until an IPO or acquisition (and that could be years away), a professional appraiser applied a 35% DLOM (discount for lack of marketability). The true value for tax purposes? $16,250. That’s the number I put on my 83(b) election form.

The Role of Discounts for Lack of Marketability (DLOM)

DLOM is the biggest factor that separates restricted stock from freely tradable stock. Even if the company is worth $100 million, if you can’t sell your shares tomorrow, they’re worth less. How big is the discount? It depends on three things:

Time horizon: How long until a liquidity event (IPO, acquisition, tender offer)? The longer the wait, the higher the discount. A company 2 years from IPO might have a 15-20% DLOM; one 5+ years out might hit 40%.
Company stage and volatility: Early-stage startups with uncertain futures carry higher discounts. You can use option-pricing models (like the Finnerty model) to quantify this. The math isn’t trivial, but the idea is simple: more risk = bigger haircut.
Dividend policy: Most startups don’t pay dividends, so you get no cash flow while waiting—that adds to the discount.

I’ve seen some companies try to use a flat 10% DLOM to make their stock look more valuable to employees. Don’t fall for it. The IRS will challenge unrealistic discounts during an audit. Stick to what independent appraisals show—they usually land between 20-40% for venture-backed startups.

IRS 409A and Fair Market Value

Section 409A of the Internal Revenue Code is the rulebook for valuing non-qualified deferred compensation, which includes restricted stock. If you get the valuation wrong (especially by underestimating it), you could face a 20% penalty plus interest. That’s why most companies hire external appraisers to perform a 409A valuation every 12 months or after a major event (like a funding round).

  ⚠️ Pain point: I once advised a founder who thought her restricted stock grant could be valued at $0.01/share because the company was early. (Big mistake.) The IRS looks at whether the valuation was based on “reasonable assumptions.” A token price won’t fly. Always get a formal 409A report—it costs $3,000-$7,000 but saves way more in penalties.

Restricted Stock vs. Stock Options

A frequent confusion is how restricted stock valuation differs from option valuation. With options (ISOs or NSOs), you use the Black-Scholes or binomial model to calculate the option’s fair value, which accounts for exercise price, volatility, time to expiration. With restricted stock, you’re valuing the underlying share itself, not a derivative. The grant price for RSUs is usually zero—you don’t pay to receive them—but the value is the FMV on vesting date.

Here’s a quick comparison table:

Aspect	Restricted Stock	Stock Options
Valuation basis	FMV of common share at grant (for restricted stock) or at vest (for RSUs)	Fair value of option using Black-Scholes
Out-of-pocket cost	Usually $0 at grant (unless restricted stock purchase)	Strike price at exercise
Discount applied	DLOM (20-40%)	Not directly; volatility captures risk
Tax timing	At vest (RSUs) or at purchase/grant (83(b) election)	At exercise for NSOs; at sale for ISOs
Typical employee preference	Less risk, lower upside	More leverage, higher potential gain

How to Negotiate Your Restricted Stock Value

If you’re joining a private company and receiving restricted stock, you don’t always have to accept the offered number. Here’s what I’ve done in practice:

Ask for the latest 409A report. Most companies will share a summary. Look at the valuation date and methodology. If it’s more than 12 months old, the value might be stale.
Compare with secondary market data. Check if shares have traded on platforms like EquityZen or Forge. If secondary prices are higher than the 409A value, the company’s FMV is likely understated (which benefits you for tax purposes but reduces your grant number).
Negotiate the number of shares, not the valuation. You can’t easily change the 409A value, but you can ask for more shares to compensate for a higher discount. I’ve seen employees double their share count by pointing out that the DLOM used was too conservative.

Common Valuation Mistakes (and How to Avoid Them)

Ignoring the vesting schedule. Unvested restricted stock isn’t worth its FMV because you might forfeit it. Some employees mentally value unvested shares at 100% of the 409A price—big mistake. If your vesting cliff is 1 year and you leave before, you get zero.
Using post-money valuation per share naively. “The company is worth $50M post-money, and there are 10M shares, so each share is $5.” That’s the price paid by preferred investors, not the FMV of common stock. Common always gets a discount (usually 20-30%).
Forgetting about the 83(b) election. If you receive restricted stock that is subject to vesting, you can file an 83(b) election within 30 days to pay tax on the value at grant date (usually lower) instead of at vest. But you need to know the grant-date FMV—and that’s exactly where the valuation matters.
Assuming all shares are equal. Some restricted stock grants have “double-trigger” acceleration or other liquidity preferences. These can affect the effective value. Check the terms in your equity agreement.

Frequently Asked Questions

What’s the difference between restricted stock and RSUs in valuation?

Restricted stock is actual stock transferred at grant (usually subject to vesting and repurchase right), so its value is the FMV at grant date minus DLOM. RSUs are a promise to deliver stock at vest—they have no value until vest, but the company reports a grant-date fair value for accounting. For tax purposes, RSUs are taxable at vest when shares are delivered. The valuation method is similar: both use the common stock FMV as the base.

How does the 409A valuation affect my restricted stock grant size?

The grant size (number of shares) is usually determined by dividing the grant value (e.g., $100,000) by the 409A FMV per share. If the FMV is $2/share, you get 50,000 shares. If the company undervalues its stock (e.g., $1/share), you’d get 100,000 shares—more shares but potentially lower dilutive percentage. Most employees prefer a lower FMV because it means more shares for the same “target value.” But if the FMV is too low, the IRS may still accept it if supported by a proper appraisal.

Can I challenge my company’s restricted stock valuation for tax purposes?

If you’re filing an 83(b) election, you’re accepting the company’s FMV as the taxable amount. You could obtain your own independent appraisal to argue a different value, but the IRS generally gives deference to the company’s 409A report if performed by a qualified appraiser. I’ve seen cases where employees successfully negotiated a lower FMV by presenting comparable company data, but it’s rare and requires strong evidence.

What happens to the valuation if the company has a down round?

The FMV typically drops, which reduces the value of outstanding restricted stock (for tax purposes) but also allows the company to grant more shares with the same budget. If you hold unvested restricted stock (not RSUs), the drop in FMV could lower your potential tax burden at vesting. But if you’ve already filed an 83(b) election at the higher price, you’ve locked in a higher tax basis—so you might overpay taxes relative to the current value. This is a risk of early exercise.

How do I calculate the DLOM for my restricted stock?

You typically don’t calculate it yourself; the 409A appraiser does. But you can understand their logic: they use models like Finnerty’s (put option model) or the Longstaff model. Key inputs: expected time to liquidity (e.g., 4 years), risk-free rate, volatility of the company’s stock. A simplified example: if the stock is worth $10 freely and liquidity is 4 years away with 50% annual volatility, the DLOM might be around 30%. For a more precise estimate, use online DLOM calculators that implement the Finnerty model.

This guide is based on my hands-on experience with dozens of startup valuations and employee equity discussions. Always consult a tax professional and a reputable 409A appraiser for your specific situation.